Literature DB >> 2879959

Influence of beta-blocker coadministration on the kinetics of isosorbide mononitrate and dinitrate.

H R Ochs, G Neugebauer, D J Greenblatt, L Labedzki.   

Abstract

The influence of beta-blocker coadministration on the kinetics of oral isosorbide-5-mononitrate (ISMN) and isosorbide dinitrate (ISDN) was studied in healthy volunteers. In the first study, 12 subjects ingested 20 mg ISMN on three occasions: in the control state, during coadministration of metipranolol (20 mg 3 times daily), or during metoprolol (100 mg twice daily). There were no significant differences among the three phases in peak serum ISMN concentration (470 ng/ml), the time of peak (0.6 h after dose), elimination half-life (4.5 h), or oral clearance (142 ml/min). In the second study, 10 subjects received 20 mg ISDN in the control state and again during coadministration of propranolol (80 mg 3 times daily). There were no differences between the two phases in peak serum ISDN concentration (20 ng/ml) or the time of peak (0.6 h). Propranolol increased, although not significantly, ISDN clearance (16.5 vs 12.3 L/min, P less than 0.1), and had no effect on total area under the curve for ISMN, the major metabolite of ISDN. Thus, therapeutic doses of these beta-blockers have a minimal influence on the kinetics of single doses of ISMN or ISDN in healthy individuals.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2879959     DOI: 10.1007/bf01734458

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  16 in total

1.  [Pharmacokinetics and metabolism of organic nitrates].

Authors:  H Steudel
Journal:  Z Kardiol       Date:  1985

2.  Determination of deacetylmetipranolol in body fluids by gas chromatography--chemical-ionization mass spectrometry.

Authors:  R Endele; M Senn; U Abshagen
Journal:  J Chromatogr       Date:  1982-01-08

3.  Single administration of atenolol does not influence the kinetics of orally given isosorbide dinitrate.

Authors:  M G Bogaert; M T Rosseel; K Bruyneel
Journal:  Int J Clin Pharmacol Res       Date:  1983

4.  Plasma concentrations and bioavailability of isosorbide dinitrate and pindolol from a combination formulation.

Authors:  L F Chasseaud; E Doyle; T Taylor; A Darragh
Journal:  Biopharm Drug Dispos       Date:  1981 Jul-Sep       Impact factor: 1.627

5.  Propranolol interactions with diazepam, lorazepam, and alprazolam.

Authors:  H R Ochs; D J Greenblatt; B Verburg-Ochs
Journal:  Clin Pharmacol Ther       Date:  1984-10       Impact factor: 6.875

6.  Pharmacokinetics of metipranolol in normal man.

Authors:  U Abshagen; G Betzien; B Kaufmann; G Endele
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Bioequivalence of a sustained-release isosorbide dinitrate formulation at steady-state.

Authors:  T Taylor; L F Chasseaud; R M Major; F C Leaf; R Bonn; A Darragh; R F Lambe
Journal:  Biopharm Drug Dispos       Date:  1985 Apr-Jun       Impact factor: 1.627

8.  Effects and pharmacokinetics of isosorbide dinitrate in normal man.

Authors:  S Spörl-Radun; G Betzien; B Kaufmann; V Liede; U Abshagen
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

9.  Impairment of antipyrine clearance in humans by propranolol.

Authors:  D J Greenblatt; K Franke; D H Huffman
Journal:  Circulation       Date:  1978-06       Impact factor: 29.690

10.  Kinetics of 1,2-dinitroglycerin following sustained release nitroglycerin: influence of propranolol and metoprolol.

Authors:  H R Ochs; B Verburg-Ochs; D J Greenblatt
Journal:  Klin Wochenschr       Date:  1985-11-15
View more
  3 in total

1.  Influence of exercise on plasma concentrations of isosorbide dinitrate.

Authors:  M G Bogaert; R A Lefebvre; M T Rosseel; J Bouckaert
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Investigation of a possible pharmacokinetic interaction between ibopamine and isosorbide-5-mononitrate.

Authors:  R A Lefebvre; G De Wilde; M T Rosseel; D Duprez; J De Sutter; F Pocchiari
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of nitrates.

Authors:  M G Bogaert
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.